Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 181-184

  Kim, An Na ^a   Jeon, Woo Kwang ^a   Lim, Kyu Hyoung ^a   Lee, Hui Young ^a   Kim, Woo Jin ^a   Kim, Byung Chul ^a  

^a Kangwon National University   (South Korea)

Author keywords

E cadherin; Fyn; P38; Snail; TGF beta1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE FYN; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

CADHERINS; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-FYN; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

GASTROPODA;

EID: 79953161516     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.134     Document Type: Article

References (22)

1. Moustakas A., Heldin C.H. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007, 98:1512-1520.
2. Shook D., Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 2003, 120:1351-1383.
3. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
4. Peinado H., Quintanilla M., Cano A. Transcriptional regulation of cadherines during development and carcinogenesis. Int. J. Dev. Biol. 2004, 48:365-375.
5. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
6. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
7. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 2000, 342:1350-1358.
8. Dennler S., Goumans M.J., ten Dijke P. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 2002, 71:731-740.
9. Nawshad A., Lagamba D., Polad A., Hay E.D. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005, 179:11-23.
10. Zavadil J., Böttinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
11. Saika S., Kono-Saika S., Ohnishi Y., Sato M., Muragaki Y., Ooshima A., Flanders K.C., Yoo J., Anzano M., Liu C.Y., Kao W.W., Roberts A.B. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am. J. Pathol. 2004, 164:651-663.
12. Itoh S., Thorikay M., Kowanetz M., Moustakas A., Itoh F., Heldin C.H., ten Dijke P. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 2003, 278:3751-3761.
13. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell. Biochem. 2005, 95:918-931.
14. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal trans differentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 2001, 12:27-36.
15. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 2000, 275:36803-36810.
16. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.
17. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13:513-609.
18. Mandal M., Myers J.N., Lippman S.M., Johnson F.M., Williams M.D., Rayala S., Ohshiro K., Rosenthal D.I., Weber R.S., Gallick G.E., El-Naggar A.K. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008, 112:2088-2100.
19. Thomas S., Overdevest J.B., Nitz M.D., Williams P.D., Owens C.R., Sanchez-Carbayo M., Frierson H.F., Schwartz M.A., Theodorescu D. Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res. 2011, 71:831-842.
20. Mahon F.X., Hayette S., Lagarde V., Belloc F., Turcq B., Nicolini F., Belanger C., Manley P.W., Leroy C., Etienne G., Roche S., Pasquet J.M. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Res. 2008, 68:9809-9816.
21. Lee S.A., Kim E.Y., Jeon K.W., Woo C.H., Choe J., Han S., Kim B.C. The inhibitory effect of raloxifene on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells is mediated through a ROS/p38 MAPK/CREB pathway to the up-regulation of heme oxygenase-1 independent of estrogen receptor. Biochimie 2011, 93:168-174.
22. Nyormoi O., Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin. Exp. Metastasis 2003, 20:251-263.